Cyclerion approached us as a soon-to-be spinoff of Ironwood Pharmaceuticals early in 2019. They were in need of messaging, brand identity, and all of the supporting assets too.
Orrbitt worked with Cyclerion to create their new logo first. We followed up with a color palette and brand guidelines. After that, we created new PowerPoint decks and templates, environmental branding elements, and a new corporate website along with a template for investor relations pages for NASDAQ. Cyclerion launched in April 2019 and is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases.
“Zones” highlight UX and clickpath strategy for content layout.
Research-based creativity helps you improve the quality of life for your patients, convey science to your investors, and recruit the brightest minds.
The work you are doing is important, and so are first impressions. Custom designed, branded decks ensure your first impression is a great one.